carbapenems has been researched along with fibrinogen in 1 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (fibrinogen) | Trials (fibrinogen) | Recent Studies (post-2010) (fibrinogen) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 34,477 | 1,707 | 7,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, XR; Fan, L; Li, WC; Lou, R; Qu, X; Wang, YG; Wang, ZZ; Wu, YC; Yan, SY; Zhang, L; Zhang, W | 1 |
1 other study(ies) available for carbapenems and fibrinogen
| Article | Year |
|---|---|
Clinical efficacy and safety of tigecycline based on therapeutic drug monitoring for carbapenem-resistant Gram-negative bacterium pneumonia in intensive care units.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Fibrinogen; Gram-Negative Bacteria; Humans; Intensive Care Units; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Tigecycline; Treatment Outcome | 2023 |